Drug Profile
Cupressus arizonica pollen allergy immunotherapy - Laboratorios Leti
Alternative Names: Cupressus arizonica - Laboratorios Leti; Cupressus arizonica allergen extract - Laboratorios LetiLatest Information Update: 20 Nov 2018
Price :
$50
*
At a glance
- Originator Laboratorios LETI
- Class Allergens; Antiallergics; Tree pollen allergy immunotherapies
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Tree pollen hypersensitivity
Most Recent Events
- 20 Nov 2018 No recent reports of development identified phase-II for Tree pollen hypersensitivity in Spain (Parenteral)
- 01 Nov 2015 Phase-II clinical trials in Tree pollen hypersensitivity in Spain (Parenteral) (NCT02512653)